{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:37:52Z","timestamp":1791041872935,"version":"4.1.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23\\u202FK05538"],"award-info":[{"award-number":["23\\u202FK05538"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bcp.2024.116124","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T03:49:55Z","timestamp":1710301795000},"page":"116124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models"],"prefix":"10.1016","volume":"228","author":[{"given":"Yasuhiro","family":"Uno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116124_b0005","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0021-9258(18)60338-2","article-title":"A new cytochrome in liver microsomes","volume":"237","author":"Omura","year":"1962","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx500444e","article-title":"Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals","volume":"28","author":"Rendic","year":"2015","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0015","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0003-9861(71)90048-8","article-title":"The distinct nature and function of NADPH-cytochrome c reductase and the NADPH-dependent mixed-function amine oxidase of porcine liver microsomes","volume":"145","author":"Masters","year":"1971","journal-title":"Arch. Biochem. Biophys."},{"issue":"14","key":"10.1016\/j.bcp.2024.116124_b0020","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1016\/S0021-9258(18)50388-4","article-title":"The liver microsomal FAD-containing monooxygenase. Spectral Characterization and Kinetic Studies","volume":"254","author":"Poulsen","year":"1979","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03602538809049617","article-title":"Flavin-containing monooxygenases: catalytic mechanism and substrate specificities","volume":"19","author":"Ziegler","year":"1988","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pharmthera.2005.01.001","article-title":"Mammalian flavin-containing monooxygenases: structure\/function, genetic polymorphisms and role in drug metabolism","volume":"106","author":"Krueger","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116124_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.pharmtox.46.120604.141043","article-title":"Human flavin-containing monooxygenases","volume":"46","author":"Cashman","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00498254.2019.1643515","article-title":"Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease","volume":"50","author":"Phillips","year":"2020","journal-title":"Xenobiotica"},{"issue":"12","key":"10.1016\/j.bcp.2024.116124_b0045","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1021\/acs.chemrestox.6b00136","article-title":"Combining Chimeric Mice with Humanized Liver, Mass Spectrometry, and Physiologically-Based Pharmacokinetic Modeling in Toxicology","volume":"29","author":"Yamazaki","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bcp.2024.116124_b0050","doi-asserted-by":"crossref","first-page":"21419","DOI":"10.1038\/srep21419","article-title":"Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model","volume":"6","author":"Kazuki","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","author":"Danielson","year":"2002","journal-title":"Curr. Drug Metab."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bcp.2011.11.029","article-title":"In vitro drug metabolism by C-terminally truncated human flavin-containing monooxygenase 3","volume":"83","author":"Catucci","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/00498254.2013.816891","article-title":"Metabolism and disposition of the dipeptidyl peptidase IV inhibitor teneligliptin in humans","volume":"44","author":"Nakamaru","year":"2014","journal-title":"Xenobiotica"},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0075","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bcp.2013.03.020","article-title":"Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities","volume":"85","author":"Yamazaki","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"7676","key":"10.1016\/j.bcp.2024.116124_b0080","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0140-6736(70)90241-2","article-title":"Trimethylaminuria: the fish-odour syndrome","volume":"2","author":"Humbert","year":"1970","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/ejhg.2011.214","article-title":"Clinical utility gene card for: trimethylaminuria","volume":"20","author":"Shephard","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0090","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/ATVBAHA.114.303252","article-title":"Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine","volume":"34","author":"Hartiala","year":"2014","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2024.116124_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2021.100410","article-title":"An improved TK-NOG mouse as a novel platform for humanized liver that overcomes limitations in both male and female animals","volume":"42","author":"Uehara","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2024.116124_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114887","article-title":"Drug-oxidizing and conjugating non-cytochrome P450 (non-P450) enzymes in cynomolgus monkeys and common marmosets as preclinical models for humans","volume":"197","author":"Uno","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116124_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.06.008","article-title":"Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes","volume":"121","author":"Uno","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116124_b0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bcp.2017.12.015","article-title":"Genetic polymorphisms of drug-metabolizing cytochrome P450 enzymes in cynomolgus and rhesus monkeys and common marmosets in preclinical studies for humans","volume":"153","author":"Uno","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116124_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113721","article-title":"The marmoset cytochrome P450 superfamily: Sequence\/phylogenetic analyses, genomic structure, and catalytic function","volume":"171","author":"Uehara","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0120","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1124\/mol.106.022673","article-title":"CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone","volume":"70","author":"Uno","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/00498250600968275","article-title":"CYP2C76-mediated species difference in drug metabolism: a comparison of pitavastatin metabolism between monkeys and humans","volume":"37","author":"Uno","year":"2007","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/138920010791110854","article-title":"Macaque CYP2C76 encodes cytochrome P450 enzyme not orthologous to any human isozymes","volume":"11","author":"Uno","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bcp.2024.116124_b0135","article-title":"Novel cytochrome P450 1 (CYP1) genes in tree shrews are expressed and encode functional drug-metabolizing enzymes","volume":"265","author":"Uno","year":"2023","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"issue":"9\u201311","key":"10.1016\/j.bcp.2024.116124_b0140","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/00498254.2022.2148139","article-title":"A comprehensive analysis of six forms of cytochrome P450 2C (CYP2C) in pigs","volume":"52","author":"Uno","year":"2022","journal-title":"Xenobiotica"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2024.116124_b0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tox.2009.03.003","article-title":"Expression and inducibility of CYP1A1, 1A2, 1B1 by \u03b2-naphthoflavone and CYP2B22, 3A22, 3A29, 3A46 by rifampicin in the respiratory and olfactory mucosa of pig","volume":"260","author":"Messina","year":"2009","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.rvsc.2012.07.015","article-title":"Expression and inducibility of CYP1A1, 1A2, 1B1 by \u03b2-naphthoflavone and CYP2B22, CYP3As by rifampicin in heart regions and coronary arteries of pig","volume":"94","author":"Messina","year":"2013","journal-title":"Res. Vet. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0155","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jvp.12400","article-title":"Use of RNA-seq to determine variation in canine cytochrome P450 mRNA expression between blood, liver, lung, kidney and duodenum in healthy beagles","volume":"40","author":"Visser","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2024.116124_b0160","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/dmd.31.9.1161","article-title":"Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450","volume":"31","author":"Shou","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.bcp.2024.116124_b0165","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1292\/jvms.17-0192","article-title":"Biochemical characterization of variants of canine CYP1A1 using heterologous expression","volume":"79","author":"Yu","year":"2017","journal-title":"J. Vet. Med. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0170","first-page":"97","article-title":"Toxicological significance of dog liver cytochrome P-450: examination with the enzyme expressed in Saccharomyces cerevisiae using recombinant expression plasmid","volume":"269","author":"Fukuta","year":"1992","journal-title":"Mutat. Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0175","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/vms3.1188","article-title":"Metabolism of ropinirole is mediated by several canine CYP enzymes","volume":"9","author":"Tervahauta","year":"2023","journal-title":"Vet Med Sci"},{"issue":"9","key":"10.1016\/j.bcp.2024.116124_b0180","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1124\/dmd.108.022301","article-title":"Characterization of substrate specificity of dog CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes","volume":"36","author":"Mise","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/dmd.108.025312","article-title":"Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase","volume":"37","author":"Locuson","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jvp.12256","article-title":"Evaluation of tizanidine as a marker of canine CYP1A2 activity","volume":"39","author":"Locuson","year":"2016","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2024.116124_b0195","article-title":"Cannabidiol and cannabidiolic acid: Preliminary in vitro evaluation of metabolism and drug-drug interactions involving canine cytochrome P-450, UDP-glucuronosyltransferase, and P-glycoprotein","author":"Court","year":"2023","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.bcp.2024.116124_b0200","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1124\/dmd.105.003913","article-title":"Induction of CYP1A in the beagle dog by an inhibitor of kinase insert domain-containing receptor: differential effects in vitro and in vivo on mRNA and functional activity","volume":"33","author":"Gibson","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0205","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00008571-200411000-00008","article-title":"Identification of non-functional allelic variant of CYP1A2 in dogs","volume":"14","author":"Mise","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/dmd.32.2.240","article-title":"Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs","volume":"32","author":"Mise","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.bcp.2024.116124_b0215","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00498250412331285436","article-title":"Identification of the novel canine CYP1A2 1117 C > T SNP causing protein deletion","volume":"34","author":"Tenmizu","year":"2004","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/dmd.111.041848","article-title":"Phenacetin pharmacokinetics in CYP1A2-deficient beagle dogs","volume":"40","author":"Whiterock","year":"2012","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0225","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/dmd.105.008722","article-title":"The canine CYP1A2 deficiency polymorphism dramatically affects the pharmacokinetics of 4-cyclohexyl-1-ethyl-7-methylpyrido[2,3-D]-pyrimidine-2-(1H)-one (YM-64227), a phosphodiesterase type 4 inhibitor","volume":"34","author":"Tenmizu","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/mol.113.087700","article-title":"Specificity determinants of CYP1B1 estradiol hydroxylation","volume":"84","author":"Nishida","year":"2013","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1124\/dmd.109.030528","article-title":"Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5","volume":"38","author":"Wiercinska","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.bcp.2024.116124_b0240","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/00498250802474437","article-title":"Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2","volume":"38","author":"Messina","year":"2008","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/00498254.2023.2197037","article-title":"2-Oxidation, 3-methyl hydroxylation, and 6-hydroxylation of skatole, a contributor to the odour of boar-tainted pork meat, mediated by porcine liver microsomal cytochromes P450 1A2, 2A19, 2E1, and 3A22","volume":"53","author":"Uno","year":"2023","journal-title":"Xenobiotica"},{"issue":"19","key":"10.1016\/j.bcp.2024.116124_b0250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.csbj.2014.09.003","article-title":"Regulation of porcine hepatic cytochrome p450 - implication for boar taint","volume":"11","author":"Rasmussen","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1742-7843.2005.pto_148.x","article-title":"Porcine CYP2A polymorphisms and activity","volume":"97","author":"Skaanild","year":"2005","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0260","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/dmd.122.001152","article-title":"Newly Identified Tree Shrew Cytochrome P450 2A13 is Expressed in Liver and Lung and Encodes a Functional Drug-Metabolizing Enzyme Similar to Dog Cytochrome P450 2A13 and Pig Cytochrome P450 2A19","volume":"51","author":"Ushirozako","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116124_b0265","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0006-2952(99)00015-5","article-title":"Expression of CYP2A genes in human liver and extrahepatic tissues","volume":"57","author":"Koskela","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116124_b0270","first-page":"5074","article-title":"Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone","volume":"60","author":"Su","year":"2000","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116124_b0275","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1124\/dmd.110.033068","article-title":"Expression and characterization of dog cytochrome P450 2A13 and 2A25 in baculovirus-infected insect cells","volume":"38","author":"Zhou","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0280","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/dmd.119.088070","article-title":"Absolute Quantitation of Drug-Metabolizing Cytochrome P450 Enzymes and Accessory Proteins in Dog Liver Microsomes Using Label-Free Standard-Free Analysis Reveals Interbreed Variability","volume":"47","author":"Martinez","year":"2019","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1124\/dmd.106.011064","article-title":"CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline","volume":"35","author":"Fukami","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0290","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0773.1999.tb00088.x","article-title":"Cytochrome P450 sex differences in minipigs and conventional pigs","volume":"85","author":"Skaanild","year":"1999","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2024.116124_b0295","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.toxlet.2019.08.008","article-title":"Sex dictates the constitutive expression of hepatic cytochrome P450 isoforms in Gottingen minipigs","volume":"314","author":"Rasmussen","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2024.116124_b0300","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3389\/fphar.2018.00470","article-title":"The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research","volume":"9","author":"Millecam","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116124_b0305","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/00498254.2022.2141153","article-title":"Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes","volume":"52","author":"Uno","year":"2022","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0310","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11095-014-1446-8","article-title":"Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine","volume":"32","author":"Heikkinen","year":"2015","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0315","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41598-019-56660-z","article-title":"Pharmacogenomics of poor drug metabolism in Greyhounds: Cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization","volume":"10","author":"Martinez","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0320","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0026-895X(25)09688-9","article-title":"Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity","volume":"46","author":"Hasler","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2885.2009.01101.x","article-title":"Canine CYP2B11 metabolizes and is inhibited by anesthetic agents often co-administered in dogs","volume":"33","author":"Baratta","year":"2010","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0330","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/mol.65.5.1278","article-title":"Activation of the anticancer prodrugs cyclophosphamide and ifosfamide: identification of cytochrome P450 2B enzymes and site-specific mutants with improved enzyme kinetics","volume":"65","author":"Chen","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0335","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/dmd.109.030429","article-title":"Current cytochrome P450 phenotyping methods applied to metabolic drug-drug interaction prediction in dogs","volume":"38","author":"Mills","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.bcp.2024.116124_b0340","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1124\/dmd.116.071902","article-title":"Tramadol metabolism to O-desmethyl tramadol (M1) and N-desmethyl tramadol (M2) by dog liver microsomes: Species comparison and identification of responsible canine cytochrome P-450s (CYPs)","volume":"44","author":"Perez Jimenez","year":"2016","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.bcp.2024.116124_b0345","first-page":"1395","article-title":"Ordered chimerogenesis applied to CYP2B P450 enzymes","volume":"1860","author":"Lautier","year":"2016","journal-title":"BBA"},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0350","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1124\/dmd.122.000864","article-title":"Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs","volume":"50","author":"Wu","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0355","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11248-005-0199-x","article-title":"Analysis of substrate specificity of pig CYP2B22 and CYP2C49 towards herbicides by transgenic rice plants","volume":"14","author":"Kawahigashi","year":"2005","journal-title":"Transgenic Res."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0360","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1124\/dmd.122.001236","article-title":"Novel Cytochrome P450 2C94 Functionally Metabolizes Diclofenac and Omeprazole in Dogs","volume":"51","author":"Uno","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/0049825021000048782","article-title":"mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates","volume":"33","author":"Graham","year":"2003","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0370","first-page":"278","article-title":"Isolation of a new canine cytochrome P450 CDNA from the cytochrome P450 2C subfamily (CYP2C41) and evidence for polymorphic differences in its expression","volume":"26","author":"Blaisdell","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116124_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.663175","article-title":"Sequencing of the Canine Cytochrome P450 CYP2C41 Gene and Genotyping of Its Polymorphic Occurrence in 36 Dog Breeds","volume":"8","author":"Karakus","year":"2021","journal-title":"Front Vet Sci"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0380","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/bbrc.1995.1988","article-title":"Cytochrome P450 genes expressed in porcine ovaries: identification of novel forms, evidence for gene conversion, and evolutionary relationships","volume":"212","author":"Zaphiropoulos","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0385","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1124\/dmd.111.040618","article-title":"Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry [corrected]","volume":"39","author":"Achour","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0390","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1038\/s41598-019-45212-0","article-title":"Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective","volume":"9","author":"Schelstraete","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116124_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.665644","article-title":"Hepatic Cytochrome P450 Abundance and Activity in the Developing and Adult Gottingen Minipig: Pivotal Data for PBPK Modeling","volume":"12","author":"Buyssens","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0400","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.dmpk.2016.02.001","article-title":"Sex differences in constitutive mRNA levels of CYP2B22, CYP2C33, CYP2C49, CYP3A22, CYP3A29 and CYP3A46 in the pig liver: Comparison between Meishan and Landrace pigs","volume":"31","author":"Kojima","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/187231211798472539","article-title":"A non-acidic sulfaphenazole analog demonstrating high intrinsic clearance and selectivity by canine CYP2C21","volume":"5","author":"Locuson","year":"2011","journal-title":"Drug Metab. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0410","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1124\/dmd.123.001603","article-title":"Novel tree shrew cytochrome P450 2Ds (CYP2D8a and CYP2D8b) are functional drug-metabolizing enzymes that metabolize bufuralol and dextromethorphan","volume":"52","author":"Ushirozako","year":"2024","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/abbi.1998.0801","article-title":"Expression and characterization of canine cytochrome P450 2D15","volume":"357","author":"Roussel","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0420","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/abbi.1995.1307","article-title":"A new cytochrome P450 form belonging to the CYP2D in dog liver microsomes: purification, cDNA cloning, and enzyme characterization","volume":"319","author":"Sakamoto","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.bcp.2024.116124_b0425","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0090-9556(24)15037-4","article-title":"Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib","volume":"27","author":"Paulson","year":"1999","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0430","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/oxfordjournals.jbchem.a021905","article-title":"Expression and characterization of dog CYP2D15 using baculovirus expression system","volume":"123","author":"Tasaki","year":"1998","journal-title":"J. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0435","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/dmd.32.4.376","article-title":"Cloning CYP2D21 and CYP3A22 cDNAs from liver of miniature pigs","volume":"32","author":"Sakuma","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0440","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jvp.13113","article-title":"Association of cytochrome P450 2D15 (CYP2D15) nonsynonymous polymorphisms and exon 3 deleted RNA splice variant with CYP2D15 protein content and enzyme function in dog liver microsomes","volume":"46","author":"Jimenez","year":"2023","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0445","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/oxfordjournals.jbchem.a022000","article-title":"Regio- and stereoselectivity in propranolol metabolism by dog liver microsomes and the expressed dog CYP2D15","volume":"123","author":"Tasaki","year":"1998","journal-title":"J. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0450","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2885.2007.00877.x","article-title":"The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs","volume":"30","author":"Benchaoui","year":"2007","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0455","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0090-9556(25)06826-6","article-title":"Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody","volume":"23","author":"Nakamura","year":"1995","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0460","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jvp.13058","article-title":"Cytochrome P450 reaction phenotyping of itraconazole hydroxylation in the dog","volume":"45","author":"Tonero","year":"2022","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0465","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1034\/j.1600-0773.2002.t01-2-910403.x","article-title":"Is cytochrome P450 CYP2D activity present in pig liver?","volume":"91","author":"Skaanild","year":"2002","journal-title":"Pharmacol. Toxicol."},{"issue":"44","key":"10.1016\/j.bcp.2024.116124_b0470","doi-asserted-by":"crossref","first-page":"34650","DOI":"10.1074\/jbc.M004185200","article-title":"Porcine microsomal vitamin D3 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6","volume":"275","author":"Hosseinpour","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0475","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/bbrc.1997.7551","article-title":"Cloning, structure, and expression of a cDNA encoding vitamin D3 25-hydroxylase","volume":"241","author":"Postlind","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10\u201311","key":"10.1016\/j.bcp.2024.116124_b0480","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00498254.2023.2280996","article-title":"Tree shrew cytochrome P450 2E1 is a functional enzyme that metabolises chlorzoxazone and p-nitrophenol","volume":"53","author":"Ushirozako","year":"2023","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0485","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2012.11.060","article-title":"Serum androgen level is determined by autosomal dominant inheritance and regulates sex-related CYP genes in pigs","volume":"430","author":"Kojima","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bcp.2024.116124_b0490","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0090-9556(24)15173-2","article-title":"Cloning of canine cytochrome P450 2E1 cDNA: identification and characterization of two variant alleles","volume":"28","author":"Lankford","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0495","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1124\/dmd.104.003392","article-title":"Minipig cytochrome P450 2E1: comparison with human enzyme","volume":"33","author":"Baranov\u00e1","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.bcp.2024.116124_b0500","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/00498250010021684","article-title":"Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man","volume":"30","author":"Bogaards","year":"2000","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0505","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1742-7843.2007.00083.x","article-title":"Is bupropion a more specific substrate for porcine CYP2E than chlorzoxazone and p-nitrophenol?","volume":"101","author":"Skaanild","year":"2007","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0510","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1124\/dmd.122.000930","article-title":"Cytochrome P450 2J Genes Are Expressed in Dogs, Cats, and Pigs, and Encode Functional Drug-Metabolizing Enzymes","volume":"50","author":"Uno","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116124_b0515","article-title":"Newly identified cytochrome P450 3A genes of tree shrews and pigs are expressed and encode functional enzymes","volume":"267","author":"Uno","year":"2023","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116124_b0520","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/00498250802446146","article-title":"Differential expression of CYP3A12 and CYP3A26 mRNAs in canine liver and intestine","volume":"38","author":"Mealey","year":"2008","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0525","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/dmd.121.000385","article-title":"Tertiary Oxidation of Deoxycholate Is Predictive of CYP3A Activity in Dogs","volume":"49","author":"Zeng","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0530","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00498254.2023.2211673","article-title":"Liver microsomal cytochrome P450 3A-dependent drug oxidation activities in individual dogs","volume":"53","author":"Uno","year":"2023","journal-title":"Xenobiotica"},{"issue":"12","key":"10.1016\/j.bcp.2024.116124_b0535","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1124\/dmd.30.12.1344","article-title":"Involvement of CYP3A in the metabolism of eplerenone in humans and dogs: differential metabolism by CYP3A4 and CYP3A5","volume":"30","author":"Cook","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0540","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00498250600962849","article-title":"Plasma pharmacokinetics and CYP3A12-dependent metabolism of c-kit inhibitor imatinib in dogs","volume":"37","author":"Ishizuka","year":"2007","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0545","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/vco.12084","article-title":"Reaction phenotyping of vinblastine metabolism in dogs","volume":"14","author":"Achanta","year":"2016","journal-title":"Vet. Comp. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0550","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/toxsci\/kfl009","article-title":"Cloning, tissue expression, and regulation of beagle dog CYP4A genes","volume":"92","author":"Graham","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"Pt 2","key":"10.1016\/j.bcp.2024.116124_b0555","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3630297","article-title":"Cloning and expression of two novel pig liver and kidney fatty acid hydroxylases [cytochrome P450 (CYP)4A24 and CYP4A25]","volume":"363","author":"Lundell","year":"2002","journal-title":"Biochem. J"},{"issue":"13","key":"10.1016\/j.bcp.2024.116124_b0560","doi-asserted-by":"crossref","first-page":"9606","DOI":"10.1074\/jbc.M006584200","article-title":"Cloning and expression of a pig liver taurochenodeoxycholic acid 6alpha-hydroxylase (CYP4A21): a novel member of the CYP4A subfamily","volume":"276","author":"Lundell","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0565","first-page":"86","article-title":"Gene structure of pig sterol 12 \u03b1-hydroxylase (CYP8B1) and expression in fetal liver: comparison with expression of taurochenodeoxycholic acid 6 \u03b1-hydroxylase (CYP4A21)","volume":"1634","author":"Lundell","year":"2003","journal-title":"BBA"},{"issue":"8","key":"10.1016\/j.bcp.2024.116124_b0570","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1248\/bpb.b21-00333","article-title":"Androgen-Dependent Differences in the Amounts of CYP mRNAs in the Pig Kidney","volume":"44","author":"Kojima","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2024.116124_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115125","article-title":"Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats","volume":"202","author":"Uno","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116124_b0580","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1124\/dmd.109.027714","article-title":"Expression and characterization of functional dog flavin-containing monooxygenase 3","volume":"37","author":"Lickteig","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0585","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/bi00453a014","article-title":"The flavin-containing monooxygenase expressed in pig liver: primary sequence, distribution, and evidence for a single gene","volume":"29","author":"Gasser","year":"1990","journal-title":"Biochemistry"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2024.116124_b0590","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1042\/bj2870261","article-title":"Cloning, primary sequence and chromosomal localization of human FMO2, a new member of the flavin-containing mono-oxygenase family","volume":"287","author":"Dolphin","year":"1992","journal-title":"Biochem. J"},{"issue":"19","key":"10.1016\/j.bcp.2024.116124_b0595","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.1016\/S0021-9258(18)98908-8","article-title":"Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FMO1)","volume":"266","author":"Dolphin","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0600","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1203\/00006450-200202000-00018","article-title":"Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression","volume":"51","author":"Koukouritaki","year":"2002","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0605","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1432-1033.1996.00683.x","article-title":"Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04","volume":"235","author":"Dolphin","year":"1996","journal-title":"Eur. J. Biochem."},{"issue":"46","key":"10.1016\/j.bcp.2024.116124_b0610","doi-asserted-by":"crossref","first-page":"30599","DOI":"10.1074\/jbc.273.46.30599","article-title":"The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein","volume":"273","author":"Dolphin","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2024.116124_b0615","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/FPC.0b013e3283097311","article-title":"The potentially deleterious functional variant flavin-containing monooxygenase 2*1 is at high frequency throughout sub-Saharan Africa","volume":"18","author":"Veeramah","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0620","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/dmd.30.2.119","article-title":"Cloning, sequencing, and tissue-dependent expression of flavin-containing monooxygenase (FMO) 1 and FMO3 in the dog","volume":"30","author":"Lattard","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0625","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/mol.63.2.271","article-title":"Expression and characterization of functional dog flavin-containing monooxygenase 1","volume":"63","author":"Stevens","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0630","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcp.2014.04.019","article-title":"Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs","volume":"90","author":"Yamazaki","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116124_b0635","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1016\/S0021-9258(18)53500-6","article-title":"Expression in Escherichia coli of the cloned flavin-containing monooxygenase from pig liver","volume":"268","author":"Lomri","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0640","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0009-2797(01)00162-4","article-title":"Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley Rat, Minipig, and Beagle Dog","volume":"134","author":"Lu","year":"2001","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0645","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/004982598239308","article-title":"Characterization of cytochrome P450 (CYP3A12) induction by rifampicin in dog liver","volume":"28","author":"Nishibe","year":"1998","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0650","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jbt.20118","article-title":"Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes","volume":"20","author":"Graham","year":"2006","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bcp.2024.116124_b0655","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0026-895X(25)09467-2","article-title":"Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs","volume":"38","author":"Uchida","year":"1990","journal-title":"Mol. Pharmacol."},{"issue":"6\u20137","key":"10.1016\/j.bcp.2024.116124_b0660","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/00498254.2023.2266840","article-title":"Cytochrome P450 1A2 and 2C enzymes autoinduced by omeprazole in dog hepatocytes and human HepaRG and HepaSH cells are involved in omeprazole 5-hydroxylation and sulfoxidation","volume":"53","author":"Uno","year":"2023","journal-title":"Xenobiotica"},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0665","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1124\/dmd.30.11.1206","article-title":"In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs","volume":"30","author":"Graham","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0670","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0009-2797(01)00164-8","article-title":"Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs","volume":"134","author":"Kyokawa","year":"2001","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0675","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.yexcr.2017.09.011","article-title":"Induction of cytochrome P450 mRNA in porcine primary hepatocytes cultured under serum free conditions: Comparison of freshly isolated cells and cryopreserved","volume":"360","author":"Rasmussen","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2024.116124_b0680","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.crtox.2021.03.002","article-title":"Primary hepatocytes isolated from human and porcine donors display similar patterns of cytochrome p450 expression following exposure to prototypical activators of AhR, CAR and PXR","volume":"2","author":"Gerbal-Chaloin","year":"2021","journal-title":"Curr. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0685","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tox.2009.09.010","article-title":"Effect of \u03b2-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig","volume":"265","author":"Nannelli","year":"2009","journal-title":"Toxicology"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116124_b0690","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-009-0292-1","article-title":"Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs","volume":"337","author":"Nannelli","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0695","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2133\/dmpk.DMPK-11-RG-146","article-title":"Effects of time culture and prototypical cytochrome P450 3A (CYP3A) inducers on CYP2B22, CYP2C, CYP3A and nuclear receptor (NR) mRNAs in long-term cryopreserved pig hepatocytes (CPHs)","volume":"27","author":"Giantin","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.bcp.2024.116124_b0700","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.foodchem.2013.09.068","article-title":"Regulation of cytochrome P450 mRNA expression in primary porcine hepatocytes by selected secondary plant metabolites from chicory (Cichorium intybus L.)","volume":"146","author":"Rasmussen","year":"2014","journal-title":"Food Chem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116124_b0705","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3109\/00498254.2010.489125","article-title":"Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues","volume":"40","author":"Puccinelli","year":"2010","journal-title":"Xenobiotica"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2024.116124_b0710","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tox.2008.08.004","article-title":"Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig","volume":"252","author":"Nannelli","year":"2008","journal-title":"Toxicology"},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0715","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1017\/S1751731111002175","article-title":"The roles of different porcine cytochrome P450 enzymes and cytochrome b5A in skatole metabolism","volume":"6","author":"Wiercinska","year":"2012","journal-title":"Animal"},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0720","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2052.2004.01140.x","article-title":"Molecular cloning, expression and functional characterization of the cytochrome P450 2A6 gene in pig liver","volume":"35","author":"Lin","year":"2004","journal-title":"Anim. Genet."},{"key":"10.1016\/j.bcp.2024.116124_b0725","first-page":"173","article-title":"Species differences in the pharmacokinetic parameters of cytochrome P450 probe substrates between experimental animals, such as mice, rats, dogs, monkeys, and microminipigs, and humans","volume":"5","author":"Sakai","year":"2014","journal-title":"J. Drug Metab. Toxicol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116124_b0730","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00204-006-0100-6","article-title":"Genetic polymorphism of cytochrome P450s in beagles: possible influence of CYP1A2 deficiency on toxicological evaluations","volume":"80","author":"Kamimura","year":"2006","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116124_b0735","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cvsm.2013.05.001","article-title":"Canine cytochrome P-450 pharmacogenetics","volume":"43","author":"Court","year":"2013","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.bcp.2024.116124_b0740","article-title":"Transcript abundance of hepatic drug-metabolizing enzymes in two dog breeds compared with 14 species including humans","volume":"101002","author":"Uno","year":"2024","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0745","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jvp.12890","article-title":"Analysis of polymorphisms of canine Cytochrome P 450-CYP2D15","volume":"43","author":"van Hagen","year":"2020","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"4\u20135","key":"10.1016\/j.bcp.2024.116124_b0750","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jsbmb.2005.07.001","article-title":"Functional polymorphism in porcine CYP2E1 gene: Its association with skatole levels","volume":"99","author":"Lin","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0755","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/03602532.2010.549492","article-title":"Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function","volume":"43","author":"Uno","year":"2011","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116124_b0760","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/dmd.114.061275","article-title":"Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion\/nifedipine oxidase","volume":"43","author":"Hosaka","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0765","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/dmd.123.001583","article-title":"Novel cytochrome P450 2C119 enzymes in cynomolgus and rhesus macaques metabolize progesterone, diclofenac, and omeprazole","volume":"52","author":"Uno","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0770","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1538\/expanim.63.367","article-title":"Tupaia belangeri as an experimental animal model for viral infection","volume":"63","author":"Tsukiyama-Kohara","year":"2014","journal-title":"Exp. Anim."},{"issue":"3","key":"10.1016\/j.bcp.2024.116124_b0775","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0684.2003.00022.x","article-title":"The tree shrews: adjuncts and alternatives to primates as models for biomedical research","volume":"32","author":"Cao","year":"2003","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.bcp.2024.116124_b0780","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ncomms2416","article-title":"Genome of the Chinese tree shrew","volume":"4","author":"Fan","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2024.116124_b0785","article-title":"Identification of cytochrome P450 2C18 and 2C76 in tree shrews: P450 2C18 effectively oxidizes typical human P450 2C9\/2C19 chiral substrates warfarin and omeprazole with less stereoselectivity","volume":"221","author":"Uno","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116124_b0790","article-title":"Molecular and functional characterization of flavin-containing monooxygenases (FMO1-6) in tree shrews","volume":"277","author":"Uno","year":"2024","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116124_b0795","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jmp.12528","article-title":"China is facing serious experimental monkey shortage during the COVID-19 lockdown","volume":"50","author":"Tian","year":"2021","journal-title":"J. Med. Primatol."},{"issue":"7869","key":"10.1016\/j.bcp.2024.116124_b0800","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/d41586-021-01894-z","article-title":"The US is boosting funding for research monkeys in the wake of COVID","volume":"595","author":"Subbaraman","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2024.116124_b0805","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/03602532.2013.765445","article-title":"Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics","volume":"45","author":"Martinez","year":"2013","journal-title":"Drug Metab. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2024.116124_b0810","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/138920011795713698","article-title":"Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model","volume":"12","author":"Puccinelli","year":"2011","journal-title":"Curr. Drug Metab."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:38:36Z","timestamp":1777401516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":162,"alternative-id":["S0006295224001072"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116124","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116124"}}